Bio-Rad Laboratories (BIO) Total Current Liabilities (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Total Current Liabilities data on file, last reported at $917.0 million in Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 81.01% year-over-year to $917.0 million in Q1 2026; TTM through Mar 2026 was $917.0 million, a 81.01% increase from a year earlier, with the FY2025 full-year figure at $517.0 million, up 10.52% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $917.0 million, up from $517.0 million in the prior quarter.
• Over the last five years, Total Current Liabilities for BIO reached as high as $917.0 million in Q1 2026 and fell as low as $466.2 million in Q1 2024.
• Historically, Total Current Liabilities has averaged $563.8 million across 5 years, with a median of $548.9 million in 2025.
• Across the five-year window, Total Current Liabilities declined 20.94% in 2024 and surged 81.01% in 2026, its largest moves.
• Year by year, Total Current Liabilities stood at $568.7 million in 2022, then slipped by 8.07% to $522.8 million in 2023, then decreased by 10.52% to $467.8 million in 2024, then climbed by 10.52% to $517.0 million in 2025, then jumped by 77.37% to $917.0 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $917.0 million in Q1 2026, $517.0 million in Q4 2025, and $522.3 million in Q3 2025.